AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2012
Oct 2, 2012
30826_dirs_2012-10-02_087a0aa8-7c9d-4ea4-855b-58502f9856d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2012-09-27
Reporting Person: RUSCHE JAMES R (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-27 | Common Stock | S | 2053 | $5.90 | Disposed | 157068 | Direct |
| 2012-09-27 | Common Stock | S | 1138 | $5.91 | Disposed | 155930 | Direct |
| 2012-09-27 | Common Stock | S | 100 | $5.92 | Disposed | 155830 | Direct |
| 2012-09-27 | Common Stock | S | 476 | $5.93 | Disposed | 155354 | Direct |
| 2012-09-27 | Common Stock | S | 100 | $6.00 | Disposed | 155254 | Direct |
| 2012-09-27 | Common Stock | S | 1133 | $6.09 | Disposed | 154121 | Direct |
Footnotes
F1: The shares sold were previously held in a trust for Mr. Rusche's daughter.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23